SS Innovations Expands Global Reach with Robotic Systems

SS Innovations International ( (SSII) ) has shared an update.

On July 15, 2025, SS Innovations International announced the installation of over 100 SSi Mantra surgical robotic systems across India and six other countries, with more than 5,000 surgeries performed using the system, including 240 cardiac surgeries and 32 telesurgeries. This milestone reflects the growing demand for the SSi Mantra, attributed to its innovative features and cost-effectiveness, and marks a significant step in the company’s goal to democratize access to robotic surgery. The company also plans to seek regulatory approvals in the U.S. and Europe to further expand its market reach.

Spark’s Take on SSII Stock

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

SS Innovations International faces challenges in financial performance with significant profitability and cash flow issues. While technical analysis suggests a bearish trend, the company’s innovative achievements in robotic surgery and strategic expansions are notable positives. However, the weak valuation due to unprofitability tempers the overall score.

To see Spark’s full report on SSII stock, click here.

More about SS Innovations International

SS Innovations International, Inc. (Nasdaq: SSII) is a company focused on developing innovative surgical robotic technologies aimed at making robotic surgery more affordable and accessible globally. Their product lineup includes the proprietary ‘SSi Mantra’ surgical robotic system and the ‘SSi Mudra’ surgical instruments, which facilitate various surgical procedures, including robotic cardiac surgery. The company is headquartered in India and plans to expand its presence worldwide with its advanced, user-friendly, and cost-effective solutions.

Average Trading Volume: 229,077

Technical Sentiment Signal: Sell

Current Market Cap: $966.1M

Learn more about SSII stock on TipRanks’ Stock Analysis page.